Skip to main content
Equibles

Octagon Capital Advisors LP

Position in PALI — Palisade Bio, Inc.

CIK 1839435 NEW YORK, NY
Back to PALI Full portfolio

Position in PALI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$21,477,502
+$3,493,948 QoQ
Shares Held
10,276,317
0.0% QoQ
Ownership
5.90%
of shares outstanding
% of Portfolio
1.97%
of 13F equity value
Holder Rank
#6
of 124 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PALI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Octagon Capital Advisors LP holds $1,046,707,283 across 25 Biotechnology names. PALI ranks #12 (2.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 DNTH
Dianthus Therapeutics, Inc. /DE/
 1,841,667 $179,525,699
2 DFTX
Definium Therapeutics, Inc.
 2,950,000 $138,768,000
3 ABVX
Abivax S.A.
 993,000 $132,327,180
4 COGT
Cogent Biosciences, Inc.
 2,350,000 $90,945,000
5 ALMS
Alumis Inc.
 2,830,700 $79,655,898
6 AVBP
ArriVent BioPharma, Inc.
 1,971,054 $68,474,415
7 TSHA
Taysha Gene Therapies, Inc.
 9,693,244 $66,010,991
8 MIRM
Mirum Pharmaceuticals, Inc.
 338,900 $39,675,023

All Filings in PALI

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $21,477,502 10,276,317
2026-03-31 $17,983,554 10,276,317
2025-12-31 $22,484,560 9,567,898